Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M JIMENEZ

Showing results (711-720 of 848) with videos related to

Pageof 85
Sort By:
ESMO Open|April 17, 2021
Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trialE de Guillebon, M Jimenez, L Mazzarella, et al.
Nature Communications|May 28, 2025
BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stressAndreas Varkaris, Keshan Wang, Mannan Nouri, et al.
ESMO Open|December 30, 2025
HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomasD M Filippini, B Cabarrou, C Dupain, et al.
JAMA Network Open|May 5, 2026
Hematopoietic Cell Transplant Access and Patient DiversityRachel Cusatis, Jianqun Kou, Caitrin Bupp, et al.
Immunity|April 9, 2021
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variantCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Nature Microbiology|October 16, 2021
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concernLiane Dupont, Luke B Snell, Carl Graham, et al.
Medrxiv : the Preprint Server for Health Sciences|June 15, 2021
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infectionsLiane Dupont, Luke B Snell, Carl Graham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2022
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate CancerAdam G Sowalsky, Ines Figueiredo, Rosina T Lis, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2020
A systems approach delivers a functional microRNA catalog and expanded targets for seizure suppression in temporal lobe epilepsyMorten T Venø, Cristina R Reschke, Gareth Morris, et al.
Plos One|September 15, 2021
Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivationMaria Jose Lista, Pedro M Matos, Thomas J A Maguire, et al.
Pageof 85

Showing results (711-720 of 848) with videos related to

Sort By:
Pageof 85
ESMO Open|April 17, 2021
Combining immunotherapy with an epidrug in squamous cell carcinomas of different locations: rationale and design of the PEVO basket trialE de Guillebon, M Jimenez, L Mazzarella, et al.
Nature Communications|May 28, 2025
BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stressAndreas Varkaris, Keshan Wang, Mannan Nouri, et al.
ESMO Open|December 30, 2025
HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomasD M Filippini, B Cabarrou, C Dupain, et al.
JAMA Network Open|May 5, 2026
Hematopoietic Cell Transplant Access and Patient DiversityRachel Cusatis, Jianqun Kou, Caitrin Bupp, et al.
Immunity|April 9, 2021
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variantCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Nature Microbiology|October 16, 2021
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concernLiane Dupont, Luke B Snell, Carl Graham, et al.
Medrxiv : the Preprint Server for Health Sciences|June 15, 2021
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infectionsLiane Dupont, Luke B Snell, Carl Graham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2022
Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate CancerAdam G Sowalsky, Ines Figueiredo, Rosina T Lis, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 26, 2020
A systems approach delivers a functional microRNA catalog and expanded targets for seizure suppression in temporal lobe epilepsyMorten T Venø, Cristina R Reschke, Gareth Morris, et al.
Plos One|September 15, 2021
Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivationMaria Jose Lista, Pedro M Matos, Thomas J A Maguire, et al.
Pageof 85